Skip to main content
. 2015 Apr 15;8(4):6145–6153.

Table 3.

Comparison of observed index of pre-treatment and post-treatment at 6 and 12 weeks between two groups (M (QR)

Yingliu Treatment (40) Control Treatment (40)
FT3 (pmol/l) pre-treatment 18.22 (14.87) 14.25 (14.88)
6 weeks after treatment 8.92 (8.53)* 5.60 (6.42)*
Difference after 6 weeks of treatment 9.3 (6.35) 8.65 (8.46)
12 weeks after treatment 5.44 (3.52)* 5.61 (5.19)*
Difference after 12 weeks of treatment 12.78 (11.35) 8.64 (9.69)
FT4 (pmol/l) pre-treatment 46.75 (34.95) 39.34 (27.24)
6 weeks after treatment 25.76 (20.10)* 19.30 (14.00)*
Difference after 6 weeks of treatment 20.99 (14.85) 20.04 (13.24)
12 weeks after treatment 15.85 (11.64)* 16.93 (10.50)*
Difference after 12 weeks of treatment 30.90 (23.31) 22.41 (16.74)
TSH (mIU/L) pre-treatment 0.004 (0.00) 0.004 (0.00)
6 weeks after treatment 0.004 (0.003)* 0.004 (0.080)*
Difference after 6 weeks of treatment 0.00 (0.003) 0.00 (0.080)
12 weeks after treatment 0.010 (2.26)* 0.005 (0.59)*
Difference after 12 weeks of treatment -0.006 (2.26) -0.001 (0.59)
TGAb (IU/ML) pre-treatment 89.90 (370.92) 89.62 (355.11)
6 weeks after treatment 77.35 (335.90)* 83.00 (338.20)*
Difference after 6 weeks of treatment 12.55 (35.02) 6.62 (16.91)
12 weeks after treatment 65.75 (295.71)* 71.35 (334.23)*
Difference after 12 weeks of treatment 24.15 (75.21) 18.27 (20.88)
TPOAb (IU/ML) pre-treatment 54.80 (229.20) 27.80 (250.15)
6 weeks after treatment 58.50 (193.30)* 24.40 (225.60)*
Difference after 6 weeks of treatment -3.70 (35.9) 3.40 (24.55)
12 weeks after treatment 40.40 (168.83)* 24.60 (202.58)*
Difference after 12 weeks of treatment 14.40 (60.37) 3.20 (47.57)
TRAb (mIU/ML) pre-treatment 12.89 (17.10) 12.17 (27.43)
6 weeks after treatment 8.46 (12.55)* 12.68 (24.91)**
Difference after 6 weeks of treatment 4.43 (4.55) 0.51 (2.52)
12 weeks after treatment 6.17 (9.11)* 9.04 (19.57)*
Difference after 12 weeks of treatment 6.72 (7.99) 3.13 (7.86)

Compared with pre-treatment,

**

P < 0.01;

*

P < 0.05;

compared with control group,

P < 0.05.